E-LIB Suche - Ergebnisse für: Teitz, Tal

1

ERK1/2 Inhibition via the Oral Administration of Tizaterkib..:

Lutze, Richard D. ; Ingersoll, Matthew A. ; Thotam, Alena...
International Journal of Molecular Sciences. 25 (2024) 12 - p. 6305 , 2024

Link: https://doi.org/10.3390/..

2

Trametinib, a MEK1/2 Inhibitor, Protects Mice from Cisplati..:

Lutze, Richard D. ; Ingersoll, Matthew A. ; Kelmann, Regina G..
Pharmaceuticals. 17 (2024) 6 - p. 735 , 2024

Link: https://doi.org/10.3390/..

3

Repurposing AZD5438 and Dabrafenib for Cisplatin-Induced AK:

Pushpan, Chithra K. ; Kresock, Daniel F. ; Ingersoll, Matthew A....
Journal of the American Society of Nephrology. 35 (2023) 1 - p. 22-40 , 2023

Link: https://doi.org/10.1681/..

4

Dabrafenib protects from cisplatin-induced hearing loss in ..:

Ingersoll, Matthew A. ; Lutze, Richard D. ; Pushpan, Chithra K....
JCI Insight. 8 (2023) 24 - p. , 2023

Link: https://doi.org/10.1172/..

5

Dync1li1 is required for the survival of mammalian cochlear..:

Zhang, Yuan ; Zhang, Shasha ; Zhou, Han...
PLOS Genetics. 18 (2022) 6 - p. e1010232 , 2022

Link: https://doi.org/10.1371/..

6

BRAF inhibition protects against hearing loss in mice:

Ingersoll, Matthew A. ; Malloy, Emma A. ; Caster, Lauryn E....
Science Advances. 6 (2020) 49 - p. , 2020

Link: https://doi.org/10.1126/..

7

CDK2 inhibitors as candidate therapeutics for cisplatin- an..:

Teitz, Tal ; Fang, Jie ; Goktug, Asli N....
Journal of Experimental Medicine. 215 (2018) 4 - p. 1187-1203 , 2018

Link: https://doi.org/10.1084/..

8

Development of Second-Generation CDK2 Inhibitors for the Pr..:

Hazlitt, Robert A. ; Teitz, Tal ; Bonga, Justine D....
Journal of Medicinal Chemistry. 61 (2018) 17 - p. 7700-7709 , 2018

Link: https://doi.org/10.1021/..

9

Common variants in ACYP2 influence susceptibility to cispla..:

Xu, Heng ; Robinson, Giles W ; Huang, Jie...
Nature Genetics. 47 (2015) 3 - p. 263-266 , 2015

Link: https://doi.org/10.1038/..

10

Erratum: Corrigendum: Common variants in ACYP2 influence su..:

Xu, Heng ; Robinson, Giles W ; Huang, Jie...
Nature Genetics. 47 (2015) 4 - p. 423-423 , 2015

Link: https://doi.org/10.1038/..

11

Preclinical Models for Neuroblastoma: Establishing a Baseli..:

Teitz, Tal ; Stanke, Jennifer J. ; Federico, Sara...
PLoS ONE. 6 (2011) 4 - p. e19133 , 2011

Link: https://doi.org/10.1371/..

12

Halting Neuroblastoma Metastasis by Controlling Integrin-Me..:

Teitz, Tal ; Stupack, Dwayne G. ; Lahti, Jill M.
Cell Cycle. 5 (2006) 7 - p. 681-685 , 2006

Link: https://doi.org/10.4161/..

13

Potentiation of neuroblastoma metastasis by loss of caspase..:

Stupack, Dwayne G. ; Teitz, Tal ; Potter, Matthew D....
Nature. 439 (2006) 7072 - p. 95-99 , 2006

Link: https://doi.org/10.1038/..

14

Reply to "Expression and methylation of CASP8 in neuroblast..:

Teitz, Tal ; Lahti, Jill M. ; Kidd, Vincent J.
Nature Medicine. 8 (2002) 12 - p. 1335-1335 , 2002

Link: https://doi.org/10.1038/..

15

Aggressive childhood neuroblastomas do not express caspase-..:

Teitz, Tal ; Lahti, Jill M. ; Kidd, Vincent J.
Journal of Molecular Medicine. 79 (2001) 8 - p. 428-436 , 2001

Link: https://doi.org/10.1007/..